Pfizer and BionTech reported that they are seeking the United States Food and Drug Administration (FDA) to authorize the emergency use of the covid-19 booster vaccine for those over 18 years of age.
The laboratories said that after a study they concluded that a booster dose is 95% effective against the disease.